09/09/2026
Some women are posing as men just to get their hormones. That’s where menopause care is at. 🩺
A Welsh menopause specialist says patchy NHS access is pushing women to buy testosterone online — some turning up with levels up to 12× the safe range, risking permanent side effects. The problem isn’t the hormone. It’s a system where whether you get treated depends on your postcode.
The rest of this week’s access story:
→ The US FDA confirmed a demand-driven squeeze on oestradiol (MHT) patches — supply’s nearly doubled in a year after a Nov 2025 US labelling change (an American regulatory move; AU prescribing is unchanged).
→ A small UCLA study (20 women, no placebo group) found a year of estriol + progesterone eased brain fog, memory and focus — promising, but read it as an early signal, not a verdict: the lead researcher has commercial ties to the treatment.
→ A Canadian survey of 2,045 adults found 53% of women live with a chronic condition and 64% struggle to raise health topics with their GP — among Gen Z women with a chronic illness, 92% have had to repeat their full history to a new provider.
→ Oura’s IPO filing shows ~72% of its 5M paid members are women, revenue up 74% to US$1.21B — its menopause tracker now feeding real clinical referral pathways.
→ Spain’s iPremom raised EUR15M for a blood test targeting preeclampsia (which affects up to ~8% of pregnancies) from as early as nine weeks.
→ And the Australasian Menopause Society congress lands in Sydney this week (11–13 Sep) — a rare menopause headline on home soil.
Save this 🔖 and send it to a woman who’ll want to know. Every story, with sources linked, is in this week’s Bots & Gals — link in bio.
And when the news raises a question about your body, you don’t have to Google it alone. A private micro-consult® with an Anni practitioner gives you a real answer — alongside your GP of. Anni makes it better.
Which article piqued your interest the most?